Definition and description of schizophrenia in the DSM-5

Schizophrenia Research

Volumn 150, Issue 1, 2013, Pages 3-10

  Tandon, Rajiv ^a   Gaebel, Wolfgang ^b   Barch, Deanna M ^c,d,e   Bustillo, Juan ^f   Gur, Raquel E ^g,h   Heckers, Stephan ⁱ   Malaspina, Dolores ^j,k   Owen, Michael J ^l   Schultz, Susan ^m   Tsuang, Ming ^n,o,p   Van Os, Jim ^q,r   Carpenter, William ^s,t  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Department of Orthopedic Surgery   (Germany)

^c WASHINGTON UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF NEW MEXICO   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ VANDERBILT UNIVERSITY   (United States)

^j NEW YORK UNIVERSITY   (United States)

^k Creedmoor Psychiatric Center   (United States)

^l CARDIFF UNIVERSITY   (United Kingdom)

^m UNIVERSITY OF IOWA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^p HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^q MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^r KING'S COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^t VISN 5 MIRECC   (United States)

more..

Author keywords

Classification; Definition; DSM; Nosology; RDoC; Schizophrenia; Subtypes

Indexed keywords

COGNITIVE DEFECT; DELUSION; DEVELOPMENTAL DISORDER; DISEASE CLASSIFICATION; DISEASE COURSE; DISORIENTATION; DSM-5; DSM-IV; HALLUCINATION; HUMAN; ICD-11; MENTAL DISEASE; NEGATIVE SYNDROME; PRIORITY JOURNAL; RELIABILITY; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; VALIDITY;

CLASSIFICATION; CRITERIA; DEFINITION; DSM; DSM-5; HETEROGENEITY; NOSOLOGY; RDOC; SCHIZOPHRENIA; SUBTYPES;

DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; SCHIZOPHRENIA;

EID: 84884147216     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.05.028     Document Type: Review

References (86)

1. Allardyce J., McReadie R.G., Morrison G., van Os J. Do symptom dimensions or categorical diagnoses best discriminate between known risk factors for psychosis. Soc. Psychiatry Psychiatr. Epidemiol. 2007, 42:429-437.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-I) 1952, American Psychiatric Association, Washington D.C. 1st edition.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-II) 1968, American Psychiatric Association, Washington D.C. 2nd edition.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-III) 1980, American Psychiatric Association, Washington D.C. 3rd edition.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders - (DSM-III-R) 1987, American Psychiatric Association, Washington D.C., (revised). 3rd edition.
6. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders - (DSM-IV) 1994, American Psychiatric Association, Washington D.C. 4th edition.
7. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders - (DSM-IV-TR) 2000, American Psychiatric Association, Washington D.C., (Text Revision). 4th edition.
8. Andreasen N.C. The American concept of schizophrenia. Schizophr. Bull. 1989, 15:579-591.
9. Andreasen N.C., Carpenter W.T., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in Schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatry 2004, 162:441-449.
10. Andrews G., Goldberg D.P., Krueger R.F., et al. Exploring the feasibility of a meta-structure for DSM-V and ICD-11: could it improve utility and validity?. Psychol. Med. 2009, 39:1993-2000.
11. Bell V., Halligan P.W., Ellis H.D. Diagnosing delusions: a review of inter-rater reliability. Schizophr. Res. 2006, 86:76-79.
12. Black D.W., Boffeli T.J. Simple schizophrenia revisited. Compr. Psychiatry 1990, 31:344-349.
13. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 2006, 32:238-245.
14. Bleuler E. Dementia Praecox, or the group of Schizophrenias, 1911 1950, Translated by J. Zinkin, International University Press, New York.
15. Braff D.L., Ryan J., Rissling A.J., Carpenter W.T. Lack of use in the literature in the last 20years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophr. Bull. 2013, (in press).
16. Bromet E.J., Kotov R., Fochtmann L.J., et al. Diagnostic shifts during the decade following first admission for psychosis. Am. J. Psychiatry 2011, 168:1186-1194.
17. Bruijnzeel D., Tandon R. The concept of schizophrenia: from the 1850s to the DSM-5. Psychiatr. Ann. 2011, 41:289-295.
18. Cardno A.G., Jones L.A., Murphy K.C., et al. Sibling pairs with schizophrenia or schizoaffective disorder: association of subtypes, symptoms, and demographic variables. Psychol. Med. 1998, 28:815-823.
19. Carpenter W.T., Stephens J. An attempted integration of information relevant to schizophrenic subtypes. Schizophr. Bull. 1979, 5:490-506.
20. Carpenter W.T., Tandon R. Psychotic disorder in DSM-5. Summary of changes. Asian J. Psychiatry 2013, 6:266-268.
21. Carpenter W.T., Strauss J.D., Muleh S. Are there pathognomonic symptoms in schizophrenia?. Arch. Gen. Psychiatry 1973, 28:847-852.
22. Carpenter W.T., Bustillo J.R., Thaker G.K., et al. The psychoses: Cluster 3 of the proposed meta-structure for DSM-V and ICD-11. Psychol. Med. 2009, 39:2025-2042.
23. Cermolacce M., Sass L., Parnas J. What is bizarre about bizarre delusions? A critical review. Schizophr. Bull. 2010, 36:667-679.
24. Crichton P. First-rank symptoms or rank-and-file symptoms?. Br. J. Psychiatry 1996, 169:537-540.
25. David A.S., Appleby L. Diagnostic criteria in schizophrenia: accentuate the positive. Schizophr. Bull. 1992, 18:551-557.
26. Depp C.A., Moore D.J., Sitzer D., et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison with schizophrenia and normal comparison subjects. J. Affect. Disord. 2007, 101:201-209.
27. Dyck M.J., Piek J.P., Patrick J. The validity of psychiatric diagnoses: the case of 'specific' developmental disorders. Res. Rev. Disabil. 2011, 32:2704-2713.
28. Fawcett J. Affective disorders in DSM-5. Die Psychiatrie 2013, 10:18-23.
29. Flaum M., Arndt S., Andreasen N.C. The reliability of bizarre delusions. Schizophr. Bull. 1991, 32:59-65.
30. Flaum M., Andreasen N.C., Widiger T.A. Schizophrenia and other psychotic disorders in DSM-IV: final overview. DSM-IV Sourcebook 1998, volume 4:1007-1017. American Psychiatric Association, Washington D.C. T.A. Widiger, A.J. Frances, H.A. Pincus (Eds.).
31. Gaebel W. Course typologies, treatment principles, and research concepts. Pharmacopsychiatry 2004, 27:S90-S97. (Suppl.2).
32. Gaebel W. The status of psychotic disorders in ICD-11. Schizophr. Bull. 2012, 38:895-898.
33. Gaebel W., Zielasek J., Cleveland H.-R. Psychotic disorders in ICD-11. Die Psychiatrie 2013, 10:11-17.
34. Haahr U., Friis S., Larsen T.K., et al. First-episode psychosis: diagnostic stability over one and two years. Psychopathology 2008, 41:322-329.
35. Heckers S., Tandon R., Bustillo J. Catatonia in the DSM. Shall we move or not?. Schizophr. Bull. 2010, 36:205-207.
36. Helmes E., Landmark J. Subtypes of schizophrenia: a cluster analytic approach. Can J. Psychiatry 2003, 48:702-708.
37. Huber G., Gross G., Schüttler R. Schizophrenie. Verlaufs- und sozialpsychiatrische Langzeituntersuchungen an den 1945-1959 in Bonn hospitalisierten schizophrenen 1979, Kranken. Springer, Heidelberg.
38. Hyman S.E. The diagnosis of mental disorders: the problem of reification. Annu. Rev. Clin. Psychol. 2010, 6:155-179.
39. Ihara K., Morgan C., Fearon P., et al. The prevalence, diagnostic significance, and demographic characteristics of Schneiderian first-rank symptoms in an epidemiological sample of first-episode psychosis. Psychopathology 2009, 42:81-91.
40. Insel T.R. Rethinking schizophrenia. Nature 2010, 468:187-193.
41. Insel T., Cuthbert B., Garvey M., et al. Research Domain Criteria (RDoC): toward a new classification framework in mental disorders. Am. J. Psychiatry 2010, 167:748-751.
42. Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol. Psychiatry 2006, 11:815-836.
43. Jager M., Frasch K., Lang F.U., Becker T. Deconstructing schizophrenia. Dimensional models or division into subtypes. Nervenarzt 2012, 83:345-354.
44. Jansson L.B., Parnas J. Competing definitions of schizophrenia: what can be learned from polydiagnostic studies?. Schizophr. Bull. 2007, 33:1178-1200.
45. Kapur S., Phillips A.G., Insel T.R. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?. Mol. Psychiatry 2012, 17:1174-1179.
46. Keefe R.S.E. Should cognitive impairment be included in the diagnostic criteria of schizophrenia?. World Psychiatry 2008, 7:22-28.
47. Keller W.R., Fischer B.A., Carpenter W.T. Revisiting the diagnosis of schizophrenia: where have we been and where we are going?. CNS Neurosci. Ther. 2011, 17:83-88.
48. Kendell R., Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am. J. Psychiatry 2003, 160:4-12.
49. Kendell R.D., Cooper J.R., Gourlay A.J., et al. Diagnostic criteria of American and British psychiatrists. Arch. Gen. Psychiatry 1971, 25:123-130.
50. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32:214-219.
51. Korver-Nieberg N., Quee P.J., Boos H.B., Simons C.J. The validity of the DSM-IV diagnostic classification system of non-affective psychosis. Aust. N. Z. J. Psychiatry 2011, 45:1061-1068.
52. Kraepelin E. Dementia Praecox and Paraphrenia, 1919 1971, Krieger, New York. G.M. Robertson (Ed.).
53. Kupfer D.J., Regier D.A. Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am. J. Psychiatry 2011, 168:672-674.
54. Leucht S., Lasser R. The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 2006, 39:161-170.
55. Liemburg E., Castelein S., Stewart R., et al. Two subdomains of negative symptoms in psychotic disorders: established and confirmed in two large cohorts. J. Psychiatr. Res. 2013, 47:718-725.
56. Linscott R.J., Allardyce J., van Os J. Seeking verisimilitude in a class: a systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophr. Bull. 2010, 36:811-829.
57. Lykouras L., Oulis P., Daskalopolou E., et al. Clinical subtypes of schizophrenic disorders: a cluster analytic study. Psychopathology 2001, 34:23-28.
58. Maj M. Mood disorders in ICD-11 and DSM-5. Die Psychiatrie 2013, 10:24-29.
59. McGlashan T.H., Fenton W.S. Classical subtypes of schizophrenia. In DSM-IV Sourcebook 1994, volume 1:419-440. American Psychiatric Association, Washington, D.C. T.A. Widiger, A.J. Frances, H.A. Pincus (Eds.).
60. Messinger J.W., Tremeau F., Antonius D., et al. Avolition and expressive deficits capture negative symptom phenomenology: implications for schizophrenia research. Clin. Psychol. Rev. 2011, 31:161-168.
61. Mullen R. The problem of bizarre delusions. J. Nerv. Ment. Dis. 2003, 191:546-548.
62. Nordgaard J., Arnfred S.M., Handest P., Parnas J. The diagnostic status of first-rank symptoms. Schizophr. Bull. 2008, 34:137-154.
63. Peralta V., Cuesta M.J. Diagnostic significance of Schneider's first-rank symptoms in schizophrenia. Comparative study between schizophrenic and nonschizophrenic psychotic disorders. Br. J. Psychiatry 1999, 174:243-248.
64. Peralta V., Cuesta M.J. The nosology of psychotic disorders: a comparison among competing classification systems. Schizophr. Bull. 2003, 29:413-425.
65. Peralta V., Cuesta M.J. The relationship between syndromes of the psychotic illness and familial liability to schizophrenia and major mood disorders. Schizophr. Res. 2007, 91:200-209.
66. Picardi A., Viroli C., Tarsitani L. Heterogeneity and symptom structure in schizophrenia. Psychiatry Res. 2012, 198:386-394.
67. Regier D.A., Narrow W.E., Kuhl E.A., Kupfer D.J. Conceptual development of DSM-V. Am. J. Psychiatry 2009, 166:645-650.
68. Reichenberg A., Harvey P.D., Bowie C.R., et al. Neuropsychological function and dysfunction in schizophrenia and affective disorders. Schizophr. Bull. 2009, 35:1022-1029.
69. Robins E., Guze S.B. Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am. J. Psychiatry 1970, 126:983-987.
70. Sallet P.C., Elkis H., Alves T.M., et al. Rightward cerebral asymmetry in subtypes of schizophrenia according to Leonhard's classification and the DSM-IV - a structural MRI study. Psychiatry Res. Neuroimaging 2003, 123:65-79.
71. Schneider K. Clinical Psychopathology 1959, Translated by Hamilton MW, Grune and Stratton, New York.
72. Shinn A.K., Heckers S., Ongur D. The special treatment of first rank auditory hallucinations and bizarre delusions in the diagnosis of schizophrenia. Schizophr. Res. 2013, 146:17-21.
73. Strauss J.S., Bartko J.J., Carpenter W.T. The use of clustering techniques for the classification of psychiatric patients. Br. J. Psychiatry 1973, 122:531-540.
74. Strauss G.P., Horan W.P., Kirkpatrick B., et al. Deconstructing negative symptoms of schizophrenia: avolition-apathy and diminished emotional expression clusters predict clinical presentation and functional outcome. J. Psychiatr. Res. 2013, 47:783-790.
75. Tandon R. The nosology of schizophrenia: towards DSM-5 and ICD-11. Psychiatr. Clin. N. Am. 2012, 35:555-569.
76. Tandon R., Carpenter W.T. DSM-5 status of psychotic disorders: 1-year pre-publication. Schizophr. Bull. 2012, 38:369-370.
77. Tandon R., Carpenter W.T. Psychotic disorders in DSM-5. Die Psychiatrie 2013, 10:5-9.
78. Tandon R., Maj M. Nosological status and definition of schizophrenia: some considerations for DSM-V. Asian J. Psychiatry 2008, 1:22-27.
79. Tandon R., Targum S.D., Nasrallah H.A., Ross R. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. J. Psychiatr. Pract. 2006, 12:348-363.
80. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "Just the Facts". 4. Clinical features and concept. Schizophr. Res. 2009, 110:1-23.
81. Tandon R., Bruijnzeel D., Rankupalli B. Does change in definition of psychotic symptoms in diagnosis of schizophrenia in DSM-5 affect caseness?. Asian J. Psychiatry 2013, (in press).
82. Tannenberg-Karant M., Fennig S., Ram R., et al. Bizarre delusions and first-rank symptoms in a first-admission sample: a preliminary analysis of prevalence and correlates. Compr. Psychiatry 1995, 36:428-434.
83. Van Os J., Burns T., Cavallaro R., et al. Standardized remission criteria in schizophrenia. Acta Psychiatr. Scand. 2006, 113:91-95.
84. Wing J.K., Nixon J. Discriminating symptoms in schizophrenia: a report from the International Pilot Study of Schizophrenia. Arch. Gen. Psychiatry 1975, 32:953-959.
85. World Health Organization The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines (CDDG) 1992, World Health Organization, Geneva.
86. Xu T.Y. The subtypes of schizophrenia. Shanghai Arch. Psychiatr. 2011, 23:106-108.